Characteristics of the increase in plasma brain natriuretic peptide level in left ventricular systolic dysfunction, associated with muscular dystrophy in comparison with idiopathic dilated cardiomyopathy-Reference-Cited by-同舟云学术

Characteristics of the increase in plasma brain natriuretic peptide level in left ventricular systolic dysfunction, associated with muscular dystrophy in comparison with idiopathic dilated cardiomyopathy

Published:2004-11 Issue:11 Volume:14 Page:732-739
ISSN:0960-8966
Container-title:Neuromuscular Disorders
language:en
Short-container-title:Neuromuscular Disorders

Author:

Demachi Jun,Kagaya Yutaka,Watanabe Jun,Sakuma Masahito,Ikeda Jun,Kakuta Yasunori,Motoyoshi Iyoko,Kohnosu Takeshi,Sakuma Hiroaki,Shimazaki Shigeru,Sakai Hideaki,Kimpara Teiko,Takahashi Toshiaki,Omura Kiyoshi,Okada Miho,Saito Hiroshi,Shirato Kunio

Publisher

Elsevier BV

Subject

Genetics(clinical),Clinical Neurology,Neurology,Pediatrics, Perinatology, and Child Health

Reference35 articles.

1. Muscular dystrophies: diseases of the dystrophin–glycoprotein complex;Worton;Science,1995

2. Prospective study of X-linked progressive muscular dystrophy in Campania;Nigro;Muscle Nerve,1983

3. Prevalence of left ventricular systolic dysfunction in Duchenne muscular dystrophy: an echocardiographic study;de Kermadec;Am Heart J,1994

4. Sequential changes in cardiac structure and function in patients with Duchenne type muscular dystrophy: a two-dimensional echocardiographic study;Sasaki;Am Heart J,1998

5. X-chromosomal (p21) muscular dystrophy and left ventricular diastolic and systolic function;Brockmeier;Pediatr Cardiol,1998

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response;Cells;2024-07-09

2. Efficacy of tranilast in preventing exacerbating cardiac function and death from heart failure in muscular dystrophy patients with advanced-stage heart failure: A single-arm, open-label, multicenter study;2024-02-06

3. Efficacy of exon-skipping therapy for DMD cardiomyopathy with mutations in actin binding domain 1;Molecular Therapy - Nucleic Acids;2023-12

4. Cardiovascular Measures of All-Cause Mortality in Duchenne Muscular Dystrophy;Circulation: Heart Failure;2023-08

5. The association between cardiac involvement and long‐term clinical outcomes in patients with Duchenne muscular dystrophy;ESC Heart Failure;2022-05-17